Table 2 Long-term primary and secondary outcomes
Events | Treatment Strategies | No. of Patients with event (%) | P value | |
|---|---|---|---|---|
All-cause death | PCI (n = 286) | 99 (34.6) | PCI versus CABG | 0.177 |
|  | CABG (n = 129) | 36 (27.9) | PCI versus MT | 0.040 |
|  | MT (n = 296) | 127 (42.9) | CABG versus MT | 0.003 |
| Â | Â | Â | Overall | 0.008 |
Cardiac death | PCI (n = 286) | 45 (15.7) | PCI versus CABG | 0.026 |
|  | CABG (n = 129) | 10 (7.8) | PCI versus MT | 0.002 |
|  | MT (n = 296) | 77 (26.0) | CABG versus MT |  < 0.001 |
|  |  |  | Overall |  < 0.001 |
MACCE | PCI (n = 286) | 144 (50.3) | PCI versus CABG | 0.080 |
|  | CABG (n = 129) | 53 (41.1) | PCI versus MT | 0.516 |
|  | MT (n = 296) | 157 (53.0) | CABG versus MT | 0.023 |
| Â | Â | Â | Overall | 0.074 |
Myocardial infarction | PCI (n = 286) | 18 (6.3) | PCI versus CABG | 0.037 |
|  | CABG (n = 129) | 2 (1.6) | PCI versus MT | 0.648 |
|  | MT (n = 296) | 16 (5.4) | CABG versus MT | 0.070 |
| Â | Â | Â | Overall | 0.117 |
Stroke | PCI (n = 286) | 27 (9.4) | PCI versus CABG | 0.359 |
|  | CABG (n = 129) | 16 (12.4) | PCI versus MT | 0.092 |
|  | MT (n = 296) | 17 (5.7) | CABG versus MT | 0.018 |
| Â | Â | Â | Overall | 0.056 |
Unplanned revascularization | PCI (n = 286) | 24 (8.4) | PCI versus CABG | 0.020 |
|  | CABG (n = 129) | 3 (2.3) | PCI versus MT | 0.282 |
|  | MT (n = 296) | 18 (6.1) | CABG versus MT | 0.100 |
| Â | Â | Â | Overall | 0.062 |